US Bancorp’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,392
| Closed | -$4.7K | – | 4178 |
|
|
2025
Q1 | $4.7K | Sell |
7,392
-23,400
| -76% | -$14.9K | ﹤0.01% | 3664 |
|
|
2024
Q4 | $31.7K | Sell |
30,792
-3,000
| -9% | -$3.09K | ﹤0.01% | 2952 |
|
|
2024
Q3 | $39.9K | Buy |
+33,792
| New | +$39.9K | ﹤0.01% | 2844 |
|
|
2022
Q1 | – | Sell |
-50
| Closed | – | – | 4046 |
|
|
2021
Q4 | $0 | Buy |
+50
| New | – | ﹤0.01% | 4073 |
|
|
2020
Q3 | – | Sell |
-309
| Closed | -$3K | – | 3647 |
|
|
2020
Q2 | $3K | Buy |
309
+105
| +51% | +$1.02K | ﹤0.01% | 3346 |
|
|
2020
Q1 | $2K | Hold |
204
| – | – | ﹤0.01% | 3370 |
|
|
2019
Q4 | $2K | Buy |
+204
| New | +$2K | ﹤0.01% | 3404 |
|